Contacts: John Kaelblein, SBI (212) 583-0370 ext. 171, cell: (908) 296-3567
Brian Ruby, CP-PR (203) 705-9218, cell: (203) 545-3422
SMALL BONE INNOVATIONS TO MARKET AVANTA TOTAL WRIST IMPLANT
New York, NY: February 23, 2005 - The newly formed Small Bone Innovations,
LLC., (SBI) announced that it will market the Avanta Total Wrist Implant
System to surgeons specializing in small bone and joint surgery. Avanta
Orthopaedics was acquired by Viscogliosi Bros. LLC., and merged into
SBI in 2004.|
The Total Wrist is anatomically designed for minimal resection of the
distal radius and carpal bones and provided in left and right hand configuration,
in three sizes, with geometrically scaled sizes to match radio-carpal
joints. It comprises three primary articulating components: the radial,
carpal ball and carpal plate.
Anthony G. Viscogliosi, Chairman & CEO of SBI, said: “We believe
that the Total Wrist is poised for growth due to its positive outcomes
since it received a 510 (k) two years ago. Patient outcomes indicate
significant restoration of movement and an absence of pain that enables
us to position the product as a major feature of the SBI arthroplasty
SBI plans to sell and distribute the Total Wrist throughout its global
network of more than 100 distributors in 30 countries.
With the rapid increases in incidence of osteo and rheumatoid arthritis,
due principally to the growth in the aging population, SBI expects to
gain a healthy share of the world market.
The Total Wrist is indicated for all advanced forms of degeneration
or post-traumatic arthritis of the radial/carpal joint. Its configuration
requires minimal resection of the distal radius and preserves the sigmoid
notch and articulation with the head of the distal ulna. The carpal
plate has a central stem for insertion in the capitate and is fixed
to the scaphoid and hamate with carpal screws.
Small Bone Innovations, LLC (SBI) was founded in 2004 by Viscogliosi
Bros. LLC., (VB), the New York-based merchant banking firm that specializes
in the musculoskeletal /orthopedic sector. VB created SBI as the first
company to focus purely on small bone & joint science. By integrating
established companies and professionals in the field, SBI today offers
a broad , clinically proven portfolio of products and technology to
treat trauma and diseases in small bones & joints.
VB’s acquisitions and technology licenses include: Avanta
Orthopaedics (hand/wrist/elbow arthroplasty and trauma products
– USA); Envision (implant manufacturing –
USA); Actipore™ (porous metal technology –
Canada); Artelon ®(biologically active & biodegradable
technology – Sweden); Xtremi-T (resorbable trauma
technology – USA).
For more information on SBI visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. The have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases